Suprachoroidal gene transfer with nonviral nanoparticles
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Suprachoroidal gene transfer with nonviral nanoparticles provides noninvasive transgene expression in photoreceptors and RPE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Widespread expression of GFP in retina and RPE 2 months after suprachoroidal injection of NPs containing a CMV-GFP expression plasmid. Brown Norway rats were given a 3-μl suprachoroidal injection of PBAE NPs containing 1 μg of CMV-GFP expression plasmid 1 mm posterior to the limbus in the inferonasal quadrant near the vertical meridian (A). Two months after injection, rats were euthanized, eyes were frozen in embedding medium, and transverse sections were immunohistochemically stained for GFP, counterstained with Hoechst, and merged with its fluorescent image. In the inferior (B), temporal (C), superior (D), and nasal (E) meridians of a section 600 μm posterior to the limbus through anterior retina [intersections of inner surface of blue ring and white lines in (A)], there was colocalization of fluorescence with anti-GFP staining in RPE and photoreceptor inner and outer segments. At the inferior (F), temporal (G), superior (H), and nasal (I) meridians of a section 1800 μm posterior to the limbus through posterior retina, staining for GFP in RPE and photoreceptor inner and outer segments was similar to that seen in anterior retina. Occasional weak expression of GFP was seen in cells of the inner retina (arrows). Scale bar, 100 μm.](https://figures.cochat.ai/paper-figures/621bb6ef7c144529bc1bc9609e0fce89/suprachoroidal-gene-transfer-with-nonviral-nanoparticles-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This route is also being investigated for delivering non-viral vectors with promising results in animals.94”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,257 · cited 1×
“While diffusion of polymeric NPs in tissue has been previously documented ( 32 ), the lateral and radial penetration of PBAE NPs from the suprachoroidal space is most likely due to a transient pressure increase that is induced by the introduced volume into a confined space ( 33 ).”
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734 · cited 1×
“In vivo–directed evolution has resulted in new AAV vectors with reduced binding to the ILM that penetrate further into the retina after intravitreous injection, resulting in widespread transduction of photoreceptors and no inflammation in rodents; however, in nonhuman primates, intravitreous injection of these vectors…”
A combinatorial polymer library approach yields insight into nonviral gene delivery
Green, J. J., Langer, R., & Anderson, D. G. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002336 · Cited by 579 · cited 2×
“Cationic poly(-amino ester)s (PBAEs) with primary, secondary, and tertiary amines and hydrolytically cleavable ester bonds compact DNA into positively charged nanoparticles (NPs) that undergo endocytosis and endosomal escape (17, 18).”
Self-citationBennett, J., Wellman, J., Marshall, K. A., McCague, S., Ashtari, M., DiStefano-Pappas, J., Elci, O. U., Chung, D. C., Sun, J., Wright, J. F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30371-3 · Cited by 461
VEGF is major stimulator in model of choroidal neovascularization.
Kwak, N., Okamoto, N., Wood, J. M., & Campochiaro, P. A. (2000) · PubMed · Cited by 442
Self-citationOkamoto, N., Tobe, T., Hackett, S. F., Ozaki, H., Vinores, M. A., La Rochelle, W., Zack, D. J., & Campochiaro, P. A. (1998) · Retina · doi:10.1097/00006982-199805000-00034 · Cited by 365 · cited 3×
“An expression plasmid for VEGF (pVEGF) was generated by excising EGFP (enhanced GFP) from pEGFP-N1 and replacing it with the coding sequence for VEGF165 excised from pRho-hVEGF (30).”
InfluentialSelf-citationInner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357
Campochiaro, P. A., Nguyen, Q. D., Shah, S. M., Klein, M. L., Holz, E., Frank, R. N., Saperstein, D. A., Gupta, A., Stout, J. T., Macko, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.167 · Cited by 343
Self-citationCloning of a gene that is rearranged in patients with choroideraemia
Cremers, F. P. M., van de Pol, D. J. R., van Kerkhoff, L. P. M., Wieringa, B., & Ropers, H.-H. (1990) · Nature · doi:10.1038/347674a0 · Cited by 333 · cited 1×
“Choroideremia is an X-linked disease due to a mutation in the CHM gene that results in degeneration of the retinal pigmented epithelium (RPE), retina, and choroid causing visual field constriction and reduction in central vision in young males ( 4 ).”
Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo
Mangraviti, A., Tzeng, S. Y., Kozielski, K. L., Wang, Y., Jin, Y., Gullotti, D., Pedone, M., Buaron, N., Liu, A., Wilson, D. R., et al. (2015) · ACS Nano · doi:10.1021/nn504905q · Cited by 249
Self-citationPatel, S. R., Berezovsky, D. E., McCarey, B. E., Zarnitsyn, V., Edelhauser, H. F., & Prausnitz, M. R. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9872 · Cited by 241
Heier, J. S., Kherani, S., Desai, S., Dugel, P., Kaushal, S., Cheng, S. H., Delacono, C., Purvis, A., Richards, S., Le-Halpere, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30979-0 · Cited by 229
Self-citationGuerrero-Cázares, H., Tzeng, S. Y., Young, N. P., Abutaleb, A. O., Quiñones-Hinojosa, A., & Green, J. J. (2014) · ACS Nano · doi:10.1021/nn501197v · Cited by 220 · cited 1×
“Tzeng and Green (29) showed that PBAE NP analogs to PBAE 457 can undergo lyophilization and long-term storage at −20°C without losing transfection efficacy (20).”
Self-citationOkamoto, N., Tobe, T., Hackett, S. F., Ozaki, H., Vinores, M. A., LaRochelle, W. J., Zack, D. J., & Campochiaro, P. A. (1997) · Europe PMC (PubMed Central) · Cited by 212
Self-citationRakoczy, E. P., Lai, C.-M., Magno, A. L., Wikstrom, M. E., French, M. A., Pierce, C. M., Schwartz, S. D., Blumenkranz, M. S., Chalberg, T. W., Degli-Esposti, M. A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00345-1 · Cited by 189
Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
Campochiaro, P. A., Lauer, A. K., Sohn, E. H., Mir, T. A., Naylor, S., Anderton, M. C., Kelleher, M., Harrop, R., Ellis, S., & Mitrophanous, K. A. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.117 · Cited by 186
Self-citationBeneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
Xue, K., Jolly, J. K., Barnard, A. R., Rudenko, A., Salvetti, A. P., Patrício, M. I., Edwards, T. L., Groppe, M., Orlans, H. O., Tolmachova, T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0185-5 · Cited by 185
(2008) · PubMed Central · Cited by 183
Sunshine, J. C., Peng, D. Y., & Green, J. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3004176 · Cited by 171
Self-citationAnti–Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease
Campochiaro, P. A., Aiello, L. P., & Rosenfeld, P. J. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.04.056 · Cited by 151
Self-citationAAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye
Reichel, F. F., Dauletbekov, D. L., Klein, R., Peters, T., Ochakovski, G. A., Seitz, I. P., Wilhelm, B., Ueffing, M., Biel, M., Wissinger, B., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.018 · Cited by 145
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression
Ding, K., Shen, J., Hafiz, Z., Hackett, S. F., Silva, R. L. E., Khan, M., Lorenc, V. E., Chen, D., Chadha, R., Zhang, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129085 · Cited by 141
Self-citationSuprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study
Campochiaro, P. A., Wykoff, C. C., Brown, D. M., Boyer, D. S., Barakat, M., Taraborelli, D., & Noronha, G. (2017) · Ophthalmology Retina · doi:10.1016/j.oret.2017.07.013 · Cited by 115
Self-citationNatural History Of Disciform Degeneration Of The Macula
Chandra, S. R., Gragoudas, E. S., Friedman, E., Buskirk, E. M. V., & Klein, M. L. (1974) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76293-2 · Cited by 106 · cited 1×
“In patients with neovascular AMD, longstanding choroidal NV results in subretinal fibrosis, which has historically been termed a disciform scar (37).”
Chen, M., Li, X., Liu, J., Han, Y., & Cheng, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.021 · Cited by 105 · cited 1×
“Suprachoroidal injection of triamcinolone acetonide results in sustained anti-inflammatory effects in the retina (22, 23) and prolonged improvements in macular edema in patients with uveitis or retinal vein occlusion (24, 25).”
Sunshine, J. C., Sunshine, S. B., Bhutto, I. A., Handa, J. T., & Green, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037543 · Cited by 105
Self-citationTakahashi, K., Igarashi, T., Miyake, K., Kobayashi, M., Yaguchi, C., Iijima, O., Yamazaki, Y., Katakai, Y., Miyake, N., Kameya, S., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.008 · Cited by 99
Yeh, S., Kurup, S. K., Wang, R. C., Foster, C. S., Noronha, G., Nguyen, Q. D., Diana, V., & for the DOGWOOD Study Team (2018) · Retina · doi:10.1097/iae.0000000000002279 · Cited by 80 · cited 1×
“Suprachoroidal injection of triamcinolone acetonide results in sustained anti-inflammatory effects in the retina (22, 23) and prolonged improvements in macular edema in patients with uveitis or retinal vein occlusion (24, 25).”
Kim, J., Yechan, K., Tzeng, S. Y., & Green, J. J. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.05.040 · Cited by 69
Self-citationNon-viral nucleic acid delivery methods
Slivac, I., Guay, D. R. P., Mangion, M., Champeil, J., & Gaillet, B. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1248941 · Cited by 69
Kim, Y. C., Oh, K. H., Edelhauser, H. F., & Prausnitz, M. R. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.020 · Cited by 65
A Novel Assay for Quantifying the Number of Plasmids Encapsulated by Polymer Nanoparticles
Bhise, N. S., Shmueli, R. B., Gonzalez, J., & Green, J. J. (2011) · Small · doi:10.1002/smll.201101718 · Cited by 64
Self-citationAAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration
Liu, Y., Fortmann, S. D., Shen, J., Wielechowski, E., Tretiakova, A., Yoo, S., Kozarsky, K., Wang, J., Wilson, J. M., & Campochiaro, P. A. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.002 · Cited by 51
Self-citationGene delivery nanoparticles specific for human microvasculature and macrovasculature
Shmueli, R. B., Sunshine, J. C., Xu, Z., Duh, E. J., & Green, J. J. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.01.006 · Cited by 48 · cited 2×
“1A) NPs formulated at a 30 (w/w) polymer:DNA mass ratio were used on the basis of our previous findings from a high-throughput transfection screen using human RPE cells and human retinal endothelial cells (28).”
Self-citationPolymeric nucleic acid delivery for immunoengineering
Tzeng, S. Y., & Green, J. J. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.09.005 · Cited by 34 · cited 2×
“Tzeng and Green (29) showed that PBAE NP analogs to PBAE 457 can undergo lyophilization and long-term storage at −20°C without losing transfection efficacy (20).”
Self-citationYuan, S., Roy, K. L., Venken, T., Lammens, W., den Ende, W. V., & Maeyer, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037453 · Cited by 25
Cited by
The effects of PEGylation on LNP based mRNA delivery to the eye
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241006 · Cited by 194
Strategies for non-viral vectors targeting organs beyond the liver
Kim, J., Eygeris, Y., Ryals, R. C., Jozić, A., & Sahay, G. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01563-4 · Cited by 173
“Spleen-targeting PBAE NPs were cationic with a hydrodynamic size less than 100 nm (ref.”
InfluentialSelf-citationGautam, M., Jozic, A., Su, G. L.-N., Herrera-Barrera, M., Curtis, A., Arrizabalaga, S., Tschetter, W., Ryals, R. C., & Sahay, G. (2023) · Nature Communications · doi:10.1038/s41467-023-42189-3 · Cited by 123
Review of gene therapies for age-related macular degeneration
Khanani, A. M., Thomas, M. J., Aziz, A. A., Weng, C. Y., Danzig, C. J., Yiu, G., Kiss, S., Waheed, N. K., & Kaiser, P. K. (2022) · Eye · doi:10.1038/s41433-021-01842-1 · Cited by 119
“Because the suprachoroidal space is adjacent to the high blood flow of the choroid, injecting formulations with larger particle size such as a steroid emulsion, viral particles, or nanoparticles are necessary to avoid rapid egress from the suprachoroidal space [55].”
BackgroundOcular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses
Ghoraba, H. H., Akhavanrezayat, A., Karaca, I., Yavari, N., Lajevardi, S., Hwang, J., Regenold, J., Matsumiya, W., Pham, B., Zaidi, M., et al. (2022) · Clinical Ophthalmology · doi:10.2147/opth.s364200 · Cited by 76
“This route is also being investigated for delivering non-viral vectors with promising results in animals.(94) Different techniques are being used for suprachoroidal drug delivery.”
Background
Metadata
- Authors
- Shen, J., Kim, J., Tzeng, S. Y., Ding, K., Hafiz, Z., Long, D., Wang, J., Green, J. J., & Campochiaro, P. A.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Green, Jordan J.
- Campochiaro, Peter A.
- ORCID
- Venue
- Science Advances
- Published
- 2020-07-03
- Volume
- 6
- Issue
- 27
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC7458446
- OpenAlex
- W3039061026
- Cited by
- 63
- References
- 40
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 7 · 2023: 12 · 2022: 9 · 2021: 13 · 2020: 4
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R21EY026148, R01EY028996, R01EB022148)
- National Eye Institute (EY01765, RO1EY031097)
- Research to Prevent Blindness
- James and Carole Free Catalyst Award
- Barth Foundation (none)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- biodegradable nanoparticles, subretinal injection, vascular endothelial growth factor, neovascular age-related macular degeneration, subretinal neovascularization, subretinal fibrosis, photoreceptors, retinal pigment epithelium, reporter plasmid, vascular leakage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.